Research ArticleArticle
Inflammation and Disease Activity are Associated with High Circulating Cardiac Markers in Rheumatoid Arthritis Independently of Traditional Cardiovascular Risk Factors
Jérôme Avouac, Christophe Meune, Camille Chenevier-Gobeaux, Philippe Dieudé, Didier Borderie, Guillaume Lefevre, André Kahan and Yannick Allanore
The Journal of Rheumatology December 2013, jrheum.130713; DOI: https://doi.org/10.3899/jrheum.130713
Jérôme Avouac
From the Paris Descartes University, Sorbonne Paris Cité, Rheumatology A department, Cochin Hospital; Paris Descartes University, INSERM U1016 and CNRS UMR8104, Cochin Institute, Paris; Paris 13 University, University Hospital of Paris-Seine-Saint-Denis, Cardiology Department, Bobigny; Clinical Chemistry Laboratory, Cochin and Hôtel-Dieu Hospitals; Paris 7 University, Rheumatology department, Bichat Claude Bernard Hospital; Clinical Chemistry and Hormonology Department, Tenon Hospital, Paris, France. J. Avouac, MD, PhD; Y. Allanore, MD, PhD, Paris Descartes University, Sorbonne Paris Cité, Rheumatology A department, Cochin Hospital and Paris Descartes University, INSERM U1016 and CNRS UMR8104, Cochin Institute; C. Meune, MD, PhD; Paris 13 University, University Hospital of Paris-Seine-Saint-Denis, Cardiology Department; C. Chenevier-Gobeaux, MD; D. Borderie, MD, PhD; Clinical Chemistry Laboratory, Cochin and Hôtel-Dieu Hospitals; P. Dieudé, MD, PhD, Paris 7 University, Rheumatology department, Bichat Claude Bernard Hospital; G. Lefevre, MD, Clinical Chemistry and Hormonology Department, Tenon Hospital; A. Kahan, MD, PhD, Paris Descartes University, Sorbonne Paris Cité, Rheumatology A department, Cochin Hospital. Address correspondence to Dr. J. Avouac, Service de Rhumatologie A, Hôpital Cochin, Université Paris Descartes, 27 rue du Faubourg Saint-Jacques, 75014 Paris, France. E-mail: jerome.avouac@cch.aphp.fr. Accepted for publication September 17, 2013.
Christophe Meune
From the Paris Descartes University, Sorbonne Paris Cité, Rheumatology A department, Cochin Hospital; Paris Descartes University, INSERM U1016 and CNRS UMR8104, Cochin Institute, Paris; Paris 13 University, University Hospital of Paris-Seine-Saint-Denis, Cardiology Department, Bobigny; Clinical Chemistry Laboratory, Cochin and Hôtel-Dieu Hospitals; Paris 7 University, Rheumatology department, Bichat Claude Bernard Hospital; Clinical Chemistry and Hormonology Department, Tenon Hospital, Paris, France. J. Avouac, MD, PhD; Y. Allanore, MD, PhD, Paris Descartes University, Sorbonne Paris Cité, Rheumatology A department, Cochin Hospital and Paris Descartes University, INSERM U1016 and CNRS UMR8104, Cochin Institute; C. Meune, MD, PhD; Paris 13 University, University Hospital of Paris-Seine-Saint-Denis, Cardiology Department; C. Chenevier-Gobeaux, MD; D. Borderie, MD, PhD; Clinical Chemistry Laboratory, Cochin and Hôtel-Dieu Hospitals; P. Dieudé, MD, PhD, Paris 7 University, Rheumatology department, Bichat Claude Bernard Hospital; G. Lefevre, MD, Clinical Chemistry and Hormonology Department, Tenon Hospital; A. Kahan, MD, PhD, Paris Descartes University, Sorbonne Paris Cité, Rheumatology A department, Cochin Hospital. Address correspondence to Dr. J. Avouac, Service de Rhumatologie A, Hôpital Cochin, Université Paris Descartes, 27 rue du Faubourg Saint-Jacques, 75014 Paris, France. E-mail: jerome.avouac@cch.aphp.fr. Accepted for publication September 17, 2013.
Camille Chenevier-Gobeaux
From the Paris Descartes University, Sorbonne Paris Cité, Rheumatology A department, Cochin Hospital; Paris Descartes University, INSERM U1016 and CNRS UMR8104, Cochin Institute, Paris; Paris 13 University, University Hospital of Paris-Seine-Saint-Denis, Cardiology Department, Bobigny; Clinical Chemistry Laboratory, Cochin and Hôtel-Dieu Hospitals; Paris 7 University, Rheumatology department, Bichat Claude Bernard Hospital; Clinical Chemistry and Hormonology Department, Tenon Hospital, Paris, France. J. Avouac, MD, PhD; Y. Allanore, MD, PhD, Paris Descartes University, Sorbonne Paris Cité, Rheumatology A department, Cochin Hospital and Paris Descartes University, INSERM U1016 and CNRS UMR8104, Cochin Institute; C. Meune, MD, PhD; Paris 13 University, University Hospital of Paris-Seine-Saint-Denis, Cardiology Department; C. Chenevier-Gobeaux, MD; D. Borderie, MD, PhD; Clinical Chemistry Laboratory, Cochin and Hôtel-Dieu Hospitals; P. Dieudé, MD, PhD, Paris 7 University, Rheumatology department, Bichat Claude Bernard Hospital; G. Lefevre, MD, Clinical Chemistry and Hormonology Department, Tenon Hospital; A. Kahan, MD, PhD, Paris Descartes University, Sorbonne Paris Cité, Rheumatology A department, Cochin Hospital. Address correspondence to Dr. J. Avouac, Service de Rhumatologie A, Hôpital Cochin, Université Paris Descartes, 27 rue du Faubourg Saint-Jacques, 75014 Paris, France. E-mail: jerome.avouac@cch.aphp.fr. Accepted for publication September 17, 2013.
Philippe Dieudé
From the Paris Descartes University, Sorbonne Paris Cité, Rheumatology A department, Cochin Hospital; Paris Descartes University, INSERM U1016 and CNRS UMR8104, Cochin Institute, Paris; Paris 13 University, University Hospital of Paris-Seine-Saint-Denis, Cardiology Department, Bobigny; Clinical Chemistry Laboratory, Cochin and Hôtel-Dieu Hospitals; Paris 7 University, Rheumatology department, Bichat Claude Bernard Hospital; Clinical Chemistry and Hormonology Department, Tenon Hospital, Paris, France. J. Avouac, MD, PhD; Y. Allanore, MD, PhD, Paris Descartes University, Sorbonne Paris Cité, Rheumatology A department, Cochin Hospital and Paris Descartes University, INSERM U1016 and CNRS UMR8104, Cochin Institute; C. Meune, MD, PhD; Paris 13 University, University Hospital of Paris-Seine-Saint-Denis, Cardiology Department; C. Chenevier-Gobeaux, MD; D. Borderie, MD, PhD; Clinical Chemistry Laboratory, Cochin and Hôtel-Dieu Hospitals; P. Dieudé, MD, PhD, Paris 7 University, Rheumatology department, Bichat Claude Bernard Hospital; G. Lefevre, MD, Clinical Chemistry and Hormonology Department, Tenon Hospital; A. Kahan, MD, PhD, Paris Descartes University, Sorbonne Paris Cité, Rheumatology A department, Cochin Hospital. Address correspondence to Dr. J. Avouac, Service de Rhumatologie A, Hôpital Cochin, Université Paris Descartes, 27 rue du Faubourg Saint-Jacques, 75014 Paris, France. E-mail: jerome.avouac@cch.aphp.fr. Accepted for publication September 17, 2013.
Didier Borderie
From the Paris Descartes University, Sorbonne Paris Cité, Rheumatology A department, Cochin Hospital; Paris Descartes University, INSERM U1016 and CNRS UMR8104, Cochin Institute, Paris; Paris 13 University, University Hospital of Paris-Seine-Saint-Denis, Cardiology Department, Bobigny; Clinical Chemistry Laboratory, Cochin and Hôtel-Dieu Hospitals; Paris 7 University, Rheumatology department, Bichat Claude Bernard Hospital; Clinical Chemistry and Hormonology Department, Tenon Hospital, Paris, France. J. Avouac, MD, PhD; Y. Allanore, MD, PhD, Paris Descartes University, Sorbonne Paris Cité, Rheumatology A department, Cochin Hospital and Paris Descartes University, INSERM U1016 and CNRS UMR8104, Cochin Institute; C. Meune, MD, PhD; Paris 13 University, University Hospital of Paris-Seine-Saint-Denis, Cardiology Department; C. Chenevier-Gobeaux, MD; D. Borderie, MD, PhD; Clinical Chemistry Laboratory, Cochin and Hôtel-Dieu Hospitals; P. Dieudé, MD, PhD, Paris 7 University, Rheumatology department, Bichat Claude Bernard Hospital; G. Lefevre, MD, Clinical Chemistry and Hormonology Department, Tenon Hospital; A. Kahan, MD, PhD, Paris Descartes University, Sorbonne Paris Cité, Rheumatology A department, Cochin Hospital. Address correspondence to Dr. J. Avouac, Service de Rhumatologie A, Hôpital Cochin, Université Paris Descartes, 27 rue du Faubourg Saint-Jacques, 75014 Paris, France. E-mail: jerome.avouac@cch.aphp.fr. Accepted for publication September 17, 2013.
Guillaume Lefevre
From the Paris Descartes University, Sorbonne Paris Cité, Rheumatology A department, Cochin Hospital; Paris Descartes University, INSERM U1016 and CNRS UMR8104, Cochin Institute, Paris; Paris 13 University, University Hospital of Paris-Seine-Saint-Denis, Cardiology Department, Bobigny; Clinical Chemistry Laboratory, Cochin and Hôtel-Dieu Hospitals; Paris 7 University, Rheumatology department, Bichat Claude Bernard Hospital; Clinical Chemistry and Hormonology Department, Tenon Hospital, Paris, France. J. Avouac, MD, PhD; Y. Allanore, MD, PhD, Paris Descartes University, Sorbonne Paris Cité, Rheumatology A department, Cochin Hospital and Paris Descartes University, INSERM U1016 and CNRS UMR8104, Cochin Institute; C. Meune, MD, PhD; Paris 13 University, University Hospital of Paris-Seine-Saint-Denis, Cardiology Department; C. Chenevier-Gobeaux, MD; D. Borderie, MD, PhD; Clinical Chemistry Laboratory, Cochin and Hôtel-Dieu Hospitals; P. Dieudé, MD, PhD, Paris 7 University, Rheumatology department, Bichat Claude Bernard Hospital; G. Lefevre, MD, Clinical Chemistry and Hormonology Department, Tenon Hospital; A. Kahan, MD, PhD, Paris Descartes University, Sorbonne Paris Cité, Rheumatology A department, Cochin Hospital. Address correspondence to Dr. J. Avouac, Service de Rhumatologie A, Hôpital Cochin, Université Paris Descartes, 27 rue du Faubourg Saint-Jacques, 75014 Paris, France. E-mail: jerome.avouac@cch.aphp.fr. Accepted for publication September 17, 2013.
André Kahan
From the Paris Descartes University, Sorbonne Paris Cité, Rheumatology A department, Cochin Hospital; Paris Descartes University, INSERM U1016 and CNRS UMR8104, Cochin Institute, Paris; Paris 13 University, University Hospital of Paris-Seine-Saint-Denis, Cardiology Department, Bobigny; Clinical Chemistry Laboratory, Cochin and Hôtel-Dieu Hospitals; Paris 7 University, Rheumatology department, Bichat Claude Bernard Hospital; Clinical Chemistry and Hormonology Department, Tenon Hospital, Paris, France. J. Avouac, MD, PhD; Y. Allanore, MD, PhD, Paris Descartes University, Sorbonne Paris Cité, Rheumatology A department, Cochin Hospital and Paris Descartes University, INSERM U1016 and CNRS UMR8104, Cochin Institute; C. Meune, MD, PhD; Paris 13 University, University Hospital of Paris-Seine-Saint-Denis, Cardiology Department; C. Chenevier-Gobeaux, MD; D. Borderie, MD, PhD; Clinical Chemistry Laboratory, Cochin and Hôtel-Dieu Hospitals; P. Dieudé, MD, PhD, Paris 7 University, Rheumatology department, Bichat Claude Bernard Hospital; G. Lefevre, MD, Clinical Chemistry and Hormonology Department, Tenon Hospital; A. Kahan, MD, PhD, Paris Descartes University, Sorbonne Paris Cité, Rheumatology A department, Cochin Hospital. Address correspondence to Dr. J. Avouac, Service de Rhumatologie A, Hôpital Cochin, Université Paris Descartes, 27 rue du Faubourg Saint-Jacques, 75014 Paris, France. E-mail: jerome.avouac@cch.aphp.fr. Accepted for publication September 17, 2013.
Yannick Allanore
From the Paris Descartes University, Sorbonne Paris Cité, Rheumatology A department, Cochin Hospital; Paris Descartes University, INSERM U1016 and CNRS UMR8104, Cochin Institute, Paris; Paris 13 University, University Hospital of Paris-Seine-Saint-Denis, Cardiology Department, Bobigny; Clinical Chemistry Laboratory, Cochin and Hôtel-Dieu Hospitals; Paris 7 University, Rheumatology department, Bichat Claude Bernard Hospital; Clinical Chemistry and Hormonology Department, Tenon Hospital, Paris, France. J. Avouac, MD, PhD; Y. Allanore, MD, PhD, Paris Descartes University, Sorbonne Paris Cité, Rheumatology A department, Cochin Hospital and Paris Descartes University, INSERM U1016 and CNRS UMR8104, Cochin Institute; C. Meune, MD, PhD; Paris 13 University, University Hospital of Paris-Seine-Saint-Denis, Cardiology Department; C. Chenevier-Gobeaux, MD; D. Borderie, MD, PhD; Clinical Chemistry Laboratory, Cochin and Hôtel-Dieu Hospitals; P. Dieudé, MD, PhD, Paris 7 University, Rheumatology department, Bichat Claude Bernard Hospital; G. Lefevre, MD, Clinical Chemistry and Hormonology Department, Tenon Hospital; A. Kahan, MD, PhD, Paris Descartes University, Sorbonne Paris Cité, Rheumatology A department, Cochin Hospital. Address correspondence to Dr. J. Avouac, Service de Rhumatologie A, Hôpital Cochin, Université Paris Descartes, 27 rue du Faubourg Saint-Jacques, 75014 Paris, France. E-mail: jerome.avouac@cch.aphp.fr. Accepted for publication September 17, 2013.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Inflammation and Disease Activity are Associated with High Circulating Cardiac Markers in Rheumatoid Arthritis Independently of Traditional Cardiovascular Risk Factors
Jérôme Avouac, Christophe Meune, Camille Chenevier-Gobeaux, Philippe Dieudé, Didier Borderie, Guillaume Lefevre, André Kahan, Yannick Allanore
The Journal of Rheumatology Dec 2013, jrheum.130713; DOI: 10.3899/jrheum.130713
Inflammation and Disease Activity are Associated with High Circulating Cardiac Markers in Rheumatoid Arthritis Independently of Traditional Cardiovascular Risk Factors
Jérôme Avouac, Christophe Meune, Camille Chenevier-Gobeaux, Philippe Dieudé, Didier Borderie, Guillaume Lefevre, André Kahan, Yannick Allanore
The Journal of Rheumatology Dec 2013, jrheum.130713; DOI: 10.3899/jrheum.130713